| 國立臺灣大學 |
2016 |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
Huang, Chao-Yuan; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng; 黃昭源; 陳昆鋒 |
| 元培科技大學 |
2016-06 |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
郭瓊文 |
| 臺大學術典藏 |
2020-02-10T09:00:23Z |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
Huang, Chao-Yuan; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng; MONG-HSUN TSAI |
| 臺大學術典藏 |
2021-05-18T08:20:15Z |
Dovitinib acts as a novel radiosensitizer in hepatocellular carcinoma by targeting SHP-1/STAT3 signaling
|
CHAO-YUAN HUANG; Tai W.-T.; Wu S.-Y.; Shih C.-T.; Chen M.-H.; Tsai M.-H.; Kuo C.-W.; Shiau C.-W.; Hung M.-H.; Chen K.-F. |
| 臺大學術典藏 |
2022-05-05T03:09:21Z |
Dovitinib acts as a novel radiosensitizer in hepatocellular carcinoma by targeting SHP-1/STAT3 signaling
|
CHAO YUAN HUANG; Tai W.-T.; Wu S.-Y.; Shih C.-T.; Chen M.-H.; Tsai M.-H.; Kuo C.-W.; Shiau C.-W.; Hung M.-H.; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:03Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; Chen P.-J.; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺北醫學大學 |
2014 |
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
|
Gaur, S;Chen, L;Ann, V;Lin, WC;Wang, Y;Chang, VH;Hsu, NY;Shia, HS;Yen, Y |
| 臺北醫學大學 |
2014-02-04 |
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
|
Gaur, Shikha; Chen, Linling; Ann, Vincent; Lin, Wei-Chen; Wang, Yafan; Chang, Vincent HS; Hsu, Nan Yong; Shia, Her-Shuyong; Yen, Yun |
| 臺大學術典藏 |
2020-01-03T06:13:16Z |
Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/p-STAT3 Signaling in Human Breast Cancers
|
Chiu, Yi-Han;Lee, Yi-Yen;Huang, Kuo-Chin;Liu, Cheng-Chi;Lin, Chen-Si; Chiu, Yi-Han; Lee, Yi-Yen; Huang, Kuo-Chin; Liu, Cheng-Chi; Lin, Chen-Si; CHEN-SI LIN |
| 國立臺灣大學 |
2012 |
Dovitinib, a Multitargeted Kinase Inhibitor, Actively Inhibits Human Gastric Cancer Cells Via On-target Effects, and Acts Synergistically with 5-fluorouracil Via Off-target Effects with Down-regulation of Thymidylate Synthase
|
Yeh, K. H.; Gao, C. H.; Cheng, A. L.; 鄭安理; 葉坤輝 |
| 國家衛生研究院 |
2011-02 |
Dowex-50w promoted friedlander synthesis of substituted quinolines under solvent-free conditions
|
Wang, HM;Hou, RS;Du, HD;Kang, IJ;Chen, LC |
| 臺大學術典藏 |
2021-02-02T00:46:50Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; Tsai Y.-C.; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; YU-CHIEH TSAI; Wu W.-J.; Huang S.-P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:10Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; CHAO-YUAN HUANG; Tsai Y.-C.; Wu W.-J.; Huang S.-P.; Pu Y.-S. |
| 臺北醫學大學 |
2007 |
Down Regulation of Apoptosis after Left Ventricular Aneurysm Repair.
|
黃群耀; Hus CP; Huang CY; Shih CC |
| 中國醫藥大學 |
2002-04 |
Down regulation of B cells by immunization with a fusion protein of a self CD20 peptide and a foreign IgG.Fc fragment
|
許晉銓(Jim Jinn-Chyuan Sheu);(Chang TW)* |
| 中國醫藥大學 |
2007-11-16 |
Down regulation of chromatin remodeling activity triggers cell death in RSF-1/HBXAP amplified cancer cells
|
陳嘉敏(Carmen Chan); 施采琳(Tsai-Lin Shih); 蔡輔仁(Fuu-Jen Tsai); 萬磊(Lei Wan); 林應如(Ying-Ju Lin); (Tian Li Wang); (Ie Ming Shih); 許晉銓(Jinn-Chyuan Sheu)* |
| 中國醫藥大學 |
2007-11-16 |
Down regulation of chromatin remodeling activity triggers cell death in RSF-1/HBXAP amplified cancer cells
|
陳嘉敏; 施采琳(Tsai-Lin Shih); 楊振宇; 蔡輔仁(Fuu-Jen Tsai); 林應如(Ying-Ju Lin); 陳志玫(Chih-Mei Chen); 許晉銓(Jinn-Chyuan Sheu) |
| 臺北醫學大學 |
2009 |
Down regulation of gp 130 in Nasopharyngeal Carcinoma
|
林永松; Lin YS; Lin LC; Huang MH; Huang AJ; Huang YZ; |
| 中國醫藥大學 |
2007-04 |
Down regulation of IGF-I and IGF-IR gene expression in right atria tissue of ventricular septal defect infants with right atria hypoxemia.
|
(Mu-Hsin Chang); 郭薇雯; (Ping-Chun Li); (Ding-Yu Lin); 李信達(Shin-Da Lee); 蔡輔仁(Fuu-Jen Tsai); (Gwo-Ping Jong); (Yueh-Min Lin); 黃志揚; (Wen-Jun Wu)* |
| 輔英科技大學 |
2009-03-21 |
Down regulation of RhoGDI expression by TCF4 and beta-catenin in HCC
|
曹德安 |
| 臺北醫學大學 |
2003 |
Down regulation of superoxide dismutase activity and gene expression in cultured rat brain astrocytes after incubation with vitamin C.
|
蔡仁貞; Kao PF; Lee WS; Liu JC; Chan P; Tasi JC; Hus YH; Chang WY; Cheng TH; Liao SS |
